Chenze Li
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Viral Infections and Immunology Research
- Cardiomyopathy and Myosin Studies
Papers in
-
- Viral Infections and Immunology Research 9
- Cardiomyopathy and Myosin Studies 5
- Cardiovascular Function and Risk Factors 4
-
- COVID-19 Clinical Research Studies 8
- Co-authors
- Dao Wen Wang (38 shared papers)Yang Sun (16 shared papers)Bo Yu (3 shared papers)Ning Zhou (4 shared papers)Jiangang Jiang (8 shared papers)Li Ni (6 shared papers)Hualiang Jiang (2 shared papers)Jia Xuan Li (2 shared papers)
- Journals
- Science China Life Sciences (6 papers)Frontiers in Cardiovascular Medicine (6 papers)ACS Nano (3 papers)Medicine (3 papers)Frontiers of Medicine (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Chenze Li
66 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 110
- Infectious Diseases 381
- Cardiology and Cardiovascular Medicine 357
- Neurology 158
- Biological Psychiatry 18
- Molecular Biology 337
Countries citing papers authored by Chenze Li
This map shows the geographic impact of Chenze Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenze Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenze Li more than expected).
Fields of papers citing papers by Chenze Li
This network shows the impact of papers produced by Chenze Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenze Li. The network helps show where Chenze Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenze Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 129 | |
| 2 | 2021 | 119 | |
| 3 | 2020 | 115 | |
| 4 | 2020 | 112 | |
| 5 | 2022 | 82 | |
| 6 | 2020 | 60 | |
| 7 | 2019 | 50 | |
| 8 | 2020 | 45 | |
| 9 | 2019 | 41 | |
| 10 | 2022 | 34 | |
| 11 | 2021 | 32 | |
| 12 | 2021 | 30 | |
| 13 | 2021 | 28 | |
| 14 | 2022 | 28 | |
| 15 | 2018 | 28 | |
| 16 | 2020 | 26 | |
| 17 | 2020 | 26 | |
| 18 | 2019 | 26 | |
| 19 | 2022 | 25 | |
| 20 | 2023 | 21 |
About Chenze Li
Chenze Li is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases, Neurology, Molecular Biology and Epidemiology, having authored 68 papers that have together received 1.5k indexed citations. Recurring topics across this work include Viral Infections and Immunology Research (9 papers), COVID-19 Clinical Research Studies (8 papers), Long-Term Effects of COVID-19 (6 papers), Cardiomyopathy and Myosin Studies (5 papers), Cardiovascular Function and Risk Factors (4 papers), Additive Manufacturing Materials and Processes (4 papers), Cardiac Structural Anomalies and Repair (4 papers) and High Entropy Alloys Studies (4 papers). The work is most often cited by research in Infectious Diseases (381 citations), Cardiology and Cardiovascular Medicine (357 citations), Neurology (158 citations), Biological Psychiatry (18 citations) and Molecular Biology (337 citations). Chenze Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Dao Wen Wang, Yang Sun, Bo Yu, Ning Zhou, Jiangang Jiang, Li Ni, Hualiang Jiang, Jia Xuan Li, Peng Chen and Luyun Wang. Their work appears in journals such as Science China Life Sciences, Frontiers in Cardiovascular Medicine, ACS Nano, Medicine and Frontiers of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.